Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies.
Check JH, Dix E, Wilson C, Check D.
Anticancer Res. 2010 Dec;30(12):4921-3.
Related citations
MCF-7 cell apoptosis and cell cycle arrest: non-genomic effects of progesterone and mifepristone (RU-486).
Fjelldal R, Moe BT, Ørbo A, Sager G.
Anticancer Res. 2010 Dec;30(12):4835-40.
Determination of glycodelin-A expression correlated to grading and staging in ovarian carcinoma tissue.
Tsviliana A, Mayr D, Kuhn C, Kunze S, Mylonas I, Jeschke U, Friese K.
Anticancer Res. 2010 May;30(5):1637-40.
Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.
Check JH, Dix E, Cohen R, Check D, Wilson C.
Anticancer Res. 2010 Feb;30(2):623-8.
(-)-Gossypol containing hen sera and a myosin (-)-gossypol conjugate reduces the proliferation of MCF-7 cells.
Reddish JM, Ye W, Lin YC, Wick M.
Anticancer Res. 2010 Feb;30(2):439-44.
Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer.
Check JH, Sansoucie L, Chern J, Dix E.
Anticancer Res. 2010 Jan;30(1):119-22.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on